Sign Up to like & get
recommendations!
0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-211447
Abstract: While enthesitis, dactylitis and nail involvement are recognised as important outcomes of psoriatic arthritis (PsA) in the core set of domains in PsA,1 2 it is still unclear how these outcomes should best be measured.1…
read more here.
Keywords:
dactylitis nail;
nail involvement;
enthesitis dactylitis;
Sign Up to like & get
recommendations!
1
Published in 2018 at "RMD Open"
DOI: 10.1136/rmdopen-2018-000669
Abstract: Objective The Psoriatic Arthritis Long-term Assessment of Clinical Efficacy (PALACE) clinical trial programme findings demonstrated that apremilast, an oral phosphodiesterase 4 inhibitor, is effective for treating psoriatic arthritis (PsA). Enthesitis and dactylitis are difficult-to-treat features…
read more here.
Keywords:
psoriatic arthritis;
dactylitis;
enthesitis dactylitis;
palace ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "RMD Open"
DOI: 10.1136/rmdopen-2020-001217
Abstract: Objective To evaluate the effect of guselkumab on enthesitis and dactylitis in a phase II trial of patients with active psoriatic arthritis (PsA). Methods This was a phase II, randomised, placebo-controlled, double-blind trial of adults…
read more here.
Keywords:
week;
improvements enthesitis;
dactylitis;
enthesitis dactylitis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2021-002074
Abstract: Introduction Randomised controlled trials (RCTs) have compared biological and targeted systemic disease-modifying antirheumatic drugs (DMARDS) against placebo in psoriatic arthritis (PsA); few have compared them head to head. Objectives To compare the efficacy and safety…
read more here.
Keywords:
acr response;
enthesitis dactylitis;
response;
targeted systemic ... See more keywords